Table 7 Top-10 most similar adverse-event nodes.
From: A knowledge graph of clinical trials (\(\mathop {\mathtt {CTKG}}\limits\))
Similarity | Similar nodes | Possible evidence |
|---|---|---|
0.998 | Blood Luteinising Hormone Increased | Luteinising Hormone (LH) can affect the growth of Uterus Myomatosus by controling the level of estrogen23 |
Uterus Myomatosus | ||
0.997 | Inpatient Hospitalization | Excess length of inpatient hospitalization can lead to ulceration50 |
Ulceration | ||
0.997 | Major Bleeding Event | Patients receiving hemodialysis are at risk for major bleeding event and catheter-related infection51 |
Infection with Unknown Anc, Catheter-Related | ||
0.996 | Blood Luteinising Hormone Increased | The level of LH is related to uterine bleeding52 |
Major Bleeding Event | ||
0.995 | Blood Luteinising Hormone Increased | LH may regulate skin functions via LH receptors on skin53 |
Skin Procedural Complication | ||
0.995 | Skin Procedural Complication | Both are similar to the adverse-event node “Blood Luteinising Hormone Increased” |
Uterus Myomatosus | ||
0.995 | Infection with Unknown Anc, Catheter-Related | Patients with prostatic obstruction often receive urinary catheters, and are at risk for catheter-related infection54 |
Prostatic Obstruction | ||
0.994 | Gi Tract Perforation | Diabetes can induce Gi Tract Perforation55 |
Latent Autoimmune Diabetes in Adults | ||
0.994 | Cervix Carcinoma Stage III | Both of the adverse events are related with Uterus |
Vanishing Twin Syndrome | ||
0.994 | Major Bleeding Event | Uterus Myomatosus can associate with major bleeding event56 |
Uterus Myomatosus |
